<iati-activities version="2.03">
 <iati-activity default-currency="USD" dstore:dataset="bmgf-activitiesac" dstore:index="673" hierarchy="1" humanitarian="0" iati-activities:generated-datetime="2020-05-30T15:35:44" iati-activities:version="2.03" last-updated-datetime="2020-05-30T15:35:44" xml:lang="EN" xmlns:dstore="http://d-portal.org/xmlns/dstore" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <activity-date iso-date="2014-10-20" type="1">
   <narrative xml:lang="EN">Planned start date of the activity</narrative>
  </activity-date>
  <activity-date iso-date="2014-10-20" type="2"></activity-date>
  <activity-date iso-date="2018-12-31" type="3"></activity-date>
  <activity-date iso-date="2018-12-31" type="4"></activity-date>
  <activity-scope code="3"></activity-scope>
  <activity-status code="4"></activity-status>
  <budget status="2" type="1">
   <period-end iso-date="2015-12-31"></period-end>
   <period-start iso-date="2015-01-01"></period-start>
   <value currency="USD" value-date="2015-01-01">
   </value>
  </budget>
  <budget status="2" type="1">
   <period-end iso-date="2014-12-31"></period-end>
   <period-start iso-date="2014-01-01"></period-start>
   <value currency="USD" value-date="2014-01-01">
   </value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <collaboration-type code="6"></collaboration-type>
  <contact-info type="1">
   <email>info@gatsfoundation.org</email>
   <mailing-address>
    <narrative xml:lang="EN">PO Box 23350 Seattle, WA 98102-0650</narrative>
   </mailing-address>
  </contact-info>
  <country-budget-items vocabulary="1">
   <budget-item code="5.1.1" percentage="100" vocabulary="1"></budget-item>
  </country-budget-items>
  <crs-add>
   <loan-status currency="USD"></loan-status>
  </crs-add>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-finance-type code="110"></default-finance-type>
  <default-flow-type code="30"></default-flow-type>
  <default-tied-status code="5"></default-tied-status>
  <description type="1">
   <narrative xml:lang="EN">to conduct clinical trials for Ebola virus disease treatment in West Africa providing important clinical, immunologic and virologic data to inform strategic planning, design of further clinical trials and potential future treatments</narrative>
  </description>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/How-We-Work/General-Information/Grant-Opportunities">
   <category code="A10"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Tenders</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/Who-We-Are/General-Information/Leadership/Executive-Leadership-Team">
   <category code="B02"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Institutional Strategy Paper</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/What-We-Do">
   <category code="B12"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Thematic Strategy</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="https://docs.gatesfoundation.org/documents/TI_Contributions.xlsx">
   <category code="B01"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Revenue</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/How-We-Work/General-Information/Evaluation-Policy">
   <category code="A07"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Evaluations</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/How-We-Work">
   <category code="B05"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Procurement Policy and Procedure</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/Who-We-Are/General-Information/Financials">
   <category code="B07"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Country Audit Report</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/How-We-Work/General-Information/Evaluation-Policy">
   <category code="B14"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Evaluations policy</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/How-We-Work/General-Information/What-We-Do-Not-Fund">
   <category code="B08"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Exclusions Policy</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/Terms-of-Use">
   <category code="B15"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">General terms and conditions</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/Who-We-Are/General-Information/Financials">
   <category code="B06"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Institutional Audit Report</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/How-We-Work">
   <category code="B02"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Institutional Strategy Paper</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/Who-We-Are/Resources-and-Media/Annual-Letters-List">
   <category code="B02"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Institutional Strategy Paper</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/How-We-Work/General-Information/Grant-Opportunities">
   <category code="B02"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Institutional Strategy Paper</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/How-We-Work/General-Information/Information-Sharing-Approach">
   <category code="B02"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Institutional Strategy Paper</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/How-We-Work/Resources/Our-Commitment-to-Grantees">
   <category code="B02"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Institutional Strategy Paper</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/Media-Center">
   <category code="B02"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Institutional Strategy Paper</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org">
   <category code="B16"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Organization web page</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/Who-We-Are/Resources-and-Media/Annual-Reports">
   <category code="B02"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Annual report</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/How-We-Work/General-Information/Evaluation-Policy">
   <category code="B02"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Institutional Strategy Paper</narrative>
   </title>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.gatesfoundation.org/How-We-Work">
   <category code="B04"></category>
   <language code="EN"></language>
   <title>
    <narrative xml:lang="EN">Aid Allocation Policy</narrative>
   </title>
  </document-link>
  <iati-identifier>DAC-1601-OPP1122888</iati-identifier>
  <location>
   <description>
    <narrative xml:lang="EN">Guinea</narrative>
   </description>
   <exactness code="2"></exactness>
   <location-reach code="2"></location-reach>
   <name>
    <narrative xml:lang="EN">Guinea</narrative>
   </name>
  </location>
  <location>
   <description>
    <narrative xml:lang="EN">Sierra Leone</narrative>
   </description>
   <exactness code="2"></exactness>
   <location-reach code="2"></location-reach>
   <name>
    <narrative xml:lang="EN">Sierra Leone</narrative>
   </name>
  </location>
  <location>
   <description>
    <narrative xml:lang="EN">Liberia</narrative>
   </description>
   <exactness code="2"></exactness>
   <location-reach code="2"></location-reach>
   <name>
    <narrative xml:lang="EN">Liberia</narrative>
   </name>
  </location>
  <participating-org ref="DAC-1601" role="1" type="60">
   <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
  </participating-org>
  <participating-org crs-channel-code="51000" role="4">
   <narrative xml:lang="EN">Clinical Research Management, Inc.</narrative>
  </participating-org>
  <recipient-country code="GN" percentage="33"></recipient-country>
  <recipient-country code="SL" percentage="33"></recipient-country>
  <recipient-country code="LR" percentage="34"></recipient-country>
  <reporting-org ref="DAC-1601" secondary-reporter="0" type="60">
   <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
  </reporting-org>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <title>
   <narrative xml:lang="EN">Ebola: A Phase I/II Pilot Clinical Trial to Evaluate the Efficacy and Safety of Ebola Virus Disease (EVD) Convalescent Plasma (ECP) for treatment of EVD</narrative>
  </title>
  <transaction>
   <disbursement-channel code="4"></disbursement-channel>
   <provider-org ref="DAC-1601" type="60">
    <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Clinical Research Management, Inc.</narrative>
   </receiver-org>
   <recipient-region vocabulary="1"></recipient-region>
   <transaction-date iso-date="2015-06-24"></transaction-date>
   <transaction-type code="2"></transaction-type>
   <value currency="USD" value-date="2015-06-24">
   </value>
  </transaction>
  <transaction>
   <disbursement-channel code="4"></disbursement-channel>
   <provider-org ref="DAC-1601" type="60">
    <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Clinical Research Management, Inc.</narrative>
   </receiver-org>
   <recipient-region vocabulary="1"></recipient-region>
   <transaction-date iso-date="2014-10-20"></transaction-date>
   <transaction-type code="2"></transaction-type>
   <value currency="USD" value-date="2014-10-20">
   </value>
  </transaction>
  <transaction>
   <disbursement-channel code="4"></disbursement-channel>
   <provider-org ref="DAC-1601" type="60">
    <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Clinical Research Management, Inc.</narrative>
   </receiver-org>
   <recipient-region vocabulary="1"></recipient-region>
   <transaction-date iso-date="2015-09-28"></transaction-date>
   <transaction-type code="2"></transaction-type>
   <value currency="USD" value-date="2015-09-28">
   </value>
  </transaction>
  <transaction>
   <disbursement-channel code="4"></disbursement-channel>
   <provider-org ref="DAC-1601" type="60">
    <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Clinical Research Management, Inc.</narrative>
   </receiver-org>
   <recipient-region vocabulary="1"></recipient-region>
   <transaction-date iso-date="2014-10-23"></transaction-date>
   <transaction-type code="3"></transaction-type>
   <value currency="USD" value-date="2014-10-23">
   </value>
  </transaction>
  <transaction>
   <disbursement-channel code="4"></disbursement-channel>
   <provider-org ref="DAC-1601" type="60">
    <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Clinical Research Management, Inc.</narrative>
   </receiver-org>
   <recipient-region vocabulary="1"></recipient-region>
   <transaction-date iso-date="2015-06-24"></transaction-date>
   <transaction-type code="3"></transaction-type>
   <value currency="USD" value-date="2015-06-24">
   </value>
  </transaction>
  <transaction>
   <disbursement-channel code="4"></disbursement-channel>
   <provider-org ref="DAC-1601" type="60">
    <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Clinical Research Management, Inc.</narrative>
   </receiver-org>
   <recipient-region vocabulary="1"></recipient-region>
   <transaction-date iso-date="2015-10-08"></transaction-date>
   <transaction-type code="3"></transaction-type>
   <value currency="USD" value-date="2015-10-08">
   </value>
  </transaction>
 </iati-activity>
</iati-activities>
